Today: 28 February 2026
Subscribe
Browse Category

LSE:AZN 27 June 2025 - 5 December 2025

Best UK Stocks to Buy Now (5 December 2025): 10 Shares to Watch as the FTSE 100 Nears Record Highs

Best UK Stocks to Buy Now (5 December 2025): 10 Shares to Watch as the FTSE 100 Nears Record Highs

The FTSE 100 is up about 22–23% year-to-date as of December 5, 2025, and sits less than 2% below its record closing high. Today, the FTSE 100 rose 0.2% and the FTSE 250 gained 0.4%, with AstraZeneca and Ocado among notable risers. Markets expect the Bank of England to cut rates from 4% to 3.75% on December 18. UK equities continue to trade at a discount to global peers.
5 December 2025
·······
UK Stock Market Opening Preview, 5 December 2025: FTSE 100, BoE Cut Bets, Construction Slump and US Data in Focus

UK Stock Market Opening Preview, 5 December 2025: FTSE 100, BoE Cut Bets, Construction Slump and US Data in Focus

The FTSE 100 closed Thursday at 9,711, up 0.2%, led by gains in aerospace, defence, and financials, while Diageo and AJ Bell dropped sharply. UK equity funds saw £3 billion in outflows in November, marking a sixth consecutive month of net selling. The S&P Global/CIPS construction PMI fell to 39.4 in November, its lowest since May 2020, with job cuts accelerating across the sector.
4 December 2025
···········
Reeves Faces Budget Showdown: CBI Warning, OBR Downgrade and Nuclear ‘Reset’ Shape High‑Stakes Week for UK Economy

Reeves Faces Budget Showdown: CBI Warning, OBR Downgrade and Nuclear ‘Reset’ Shape High‑Stakes Week for UK Economy

UK business leaders warn Chancellor Rachel Reeves against piecemeal tax hikes ahead of Wednesday’s budget, as the OBR prepares to cut growth forecasts, widening a £20–30bn fiscal gap. Reeves is expected to scrap the two-child welfare cap and may introduce a property tax surcharge. A major review calls for a reset of nuclear regulation. AI-driven productivity gains in services offer rare optimism.
24 November 2025
·
FTSE 100’s Record Run: Inside London’s Blue-Chip Rally and What’s Next

UK Stock Market Today: FTSE 100 Suffers Biggest Fall Since April as Global Tech Jitters Hit London – 18 November 2025

The FTSE 100 fell 1.27% to 9,552 on Tuesday, its steepest one-day drop since April, as global investors sold off equities over AI bubble fears and fading US rate cut hopes. The FTSE 250 lost 1.2%, while Ocado plunged over 17% after Kroger announced warehouse closures. Banks, miners, and travel stocks led declines. A report revealed over 460,000 stolen FTSE 100 employee credentials for sale online.
18 November 2025
·····
AstraZeneca (AZN) Share Price: What to Know Before London Market Opens on 17 November 2025

AstraZeneca (AZN) Share Price: What to Know Before London Market Opens on 17 November 2025

AstraZeneca closed near record highs in London on Friday, 14 November, at about 13,532p, valuing the company near £210bn. Q3 revenue rose 10% to $15.2bn, beating forecasts, but full-year guidance was unchanged. Shareholders approved a direct NYSE listing, set for February 2026. The company reported 16 positive Phase III trials and 31 regulatory approvals so far this year.
16 November 2025
·
London Stock Exchange at Record Highs – Inside the Historic Market’s Brexit Battle and 2025 Revival

FTSE 100 Nears 10,000 as SSE Jumps on £33bn Grid Plan; Rate‑Cut Bets Lift Sentiment

London’s FTSE 100 hit a record intraday high near 9,928 on Wednesday before closing at 9,887.40, just below Tuesday’s all-time finish. SSE shares soared over 10% after announcing a £33 billion grid investment plan. Investors bet on a December Bank of England rate cut after weak UK jobs data. AstraZeneca and Vodafone also posted strong gains.
12 November 2025
·····
London Stock Exchange at Record Highs – Inside the Historic Market’s Brexit Battle and 2025 Revival

UK stocks today (6 Nov 2025): FTSE 100 edges lower before BoE decision; Sainsbury lifts profit guidance, ITV warns on Q4 ads, AstraZeneca beats

The UK FTSE 100 edged down as investors awaited the Bank of England’s rate decision, with sterling near multi-month lows. October construction PMI fell to 44.1, the steepest drop in over five years. Sainsbury raised profit guidance and announced a special dividend. ITV warned of a 9% Q4 ad revenue decline and £35m in temporary savings.
6 November 2025
········
Premarket Shock: Why CRISPR Therapeutics Could Move Big Today

Premarket Shock: Why CRISPR Therapeutics Could Move Big Today

The FDA will announce a new fast-track approval process for personalized gene-editing therapies in early November, sending CRISPR Therapeutics shares up 8% and Editas up 12%. CRSP reported over 90% mRNA correction in preclinical CTX460 data and will present Phase 1 CTX310 results at the AHA conference Nov. 8. Intellia paused a TTR amyloidosis trial after a liver injury, causing its stock to fall 46%.
2 November 2025
······
Nasdaq Climbs Record Highs Then Retreats Amid Trade and Tech News

Nasdaq Surges 1.7% on Monday After Trump Calms Trade War Fears – Tech Stocks Lead Wild Comeback

Nasdaq Composite closed at 22,513.52, up 1.39%, and Nasdaq-100 rose 1.97% to 24,697.77 on Monday, rebounding after Friday’s 3.56% plunge. Major tech stocks led gains, with Broadcom up 8% and NVIDIA up 3.6%. Qualcomm dropped 7.3% amid a Chinese antitrust probe. The U.S. government shutdown entered its tenth day, delaying key economic data.
13 October 2025
·········
AstraZeneca (AZN) Stock Skyrockets: $50B U.S. Gamble, Trump Pricing Deal & Analyst Forecasts

AstraZeneca (AZN) Stock Skyrockets: $50B U.S. Gamble, Trump Pricing Deal & Analyst Forecasts

AstraZeneca shares traded near £127.82 ($85 ADR) on Oct. 10, 2025, close to a 52-week high after a U.S. NYSE listing and a $4.5 billion Virginia plant announcement. Market cap stands at $264 billion, with 2024 revenue of $54.1 billion, up 18%. The company agreed to provide U.S. Medicaid with its lowest global drug prices. Shares have rallied over 10% since late September.
11 October 2025
···
European Stocks Climb Despite Shutdown Fears – Healthcare and Luxury Lead Gains

European Stocks Climb Despite Shutdown Fears – Healthcare and Luxury Lead Gains

The Stoxx 600 rose 0.18% to 555.53 on Sept. 29, with Germany’s DAX and the FTSE 100 also edging higher, while Italy’s FTSE MIB and Spain’s IBEX 35 slipped 0.22%. Euro-area economic confidence beat forecasts, and German import prices fell 1.5% year-on-year. Healthcare, luxury, and mining stocks gained; banks and energy lagged. GSK jumped on CEO news, while Carnival dropped 4.5% despite raising profit forecasts.
30 September 2025
······
Tariff Shocks & Rate Jitters Ignite Wild 48 Hours in European Markets

Tariff Shocks & Rate Jitters Ignite Wild 48 Hours in European Markets

European stocks hit three-week lows Thursday, then rebounded Friday as the STOXX 600 fell 0.7% before rising 0.3%. U.S. President Trump’s new tariffs on drugs and trucks triggered a 2% drop in major pharma and truck stocks. The Bank of England warned on persistent UK inflation, while the ECB and Swiss National Bank held rates steady. Germany’s consumer confidence improved; Spain’s GDP beat forecasts.
26 September 2025
········
Top Biotechnology and Health Tech Trends in 2025: Mid-Year Update and Forecast (Updated: June 27th, 2025)

Top Biotechnology and Health Tech Trends in 2025: Mid-Year Update and Forecast (Updated: June 27th, 2025)

The FDA approved Abeona’s Zevaskyn, the first cell-based gene therapy for RDEB, in April 2025, with launch set for Q3 at $3.1 million. Vertex’s CRISPR therapy Casgevy generated $2 million in Q3 2024. Novo Holdings acquired Catalent for $16.5 billion in January 2025 to secure GLP-1 drug manufacturing. Johnson & Johnson bought Intra-Cellular Therapies for $14.6 billion, expanding its neuroscience portfolio.
27 June 2025
···········
1 2
Go toTop